Difference between RO & EDI water systems

Water in the pharmaceutical industry is a dynamic and complex discussion. As an industry, pharmaceuticals largely rely on purified water as a base of all manufacturing operations. While there are a number of ways in which water is purified and consumed in pharma, two of the most common processes for pharmaceutical water purification are Reverse Osmosis (RO) and Electro De-Ionization (EDI). Understanding RO & EDI water systems thus becomes an integral part of pharma operations.

Why Are RO & EDI Water Systems Significant?

Purification processes in pharmaceuticals are largely governed by different pharmacopeias or international regulatory bodies. While they may slightly differ on the parameters, all the major pharmacopeias in the world agree that RO & EDI water systems are the most trusted methods for maintaining the optimal chemical and microbiological sanctity of the water. Even though RO & EDI water systems are both extremely popular in pharma operations, with both their objectives being the purification of water, they differ in their process, scope, and even advantages.

Reverse Osmosis (RO)

To put it in simplest terms, Reverse Osmosis or RO is a process that uses semi-permeable membranes as a filter to separate physical impurities from a solvent. In the pharmaceutical industry, it is most commonly used to purify water and produce purified water.

How Does Reverse Osmosis Help?

Reverse Osmosis is extremely efficient in getting rid of salts, sugars, dyes, bacteria, other particles, microorganisms, trihalomethanes, pesticides, and even volatile organic compounds. However, it is not able to get rid of the dissolved gases in the water, such as carbon dioxide.

Equipment Needed

Most water purification plants have a RO setup, which requires some basic equipment. A typical RO equipment consists of the following:

  • Water Pumps
  • Pre-Treatment Unit
  • Semi-Permeable Membrane
  • Disinfection Unit
  • Storage Tanks & Distribution Mechanism

The Process

The process of Reverse Osmosis starts with the pre-treatment. Depending on the quality of the feed water, chlorination, filtration, and dosing can be implemented to make sure that the water is compatible with the membranes and does not lead to corrosion and scaling. Additional steps such as flocculation and sedimentation may be needed in case of very turbid shallow water. 

After the process of pre-treatment is complete, the water is made to flow through the semi-permeable membranes using a pump. The membranes used for Reverse Osmosis are usually made of cellulose acetate and have a very small pore size. 

When water is made to flow through it at a high flow, the membranes easily allow the water to pass through but trap all the chemical impurities and microorganisms. The ‘filtered’ water is then collected using the hollow in which the membranes are fitted, and the water containing the contaminants is collected separately.

A successful RO procedure relies on the accuracy of feed water quality, membrane type, flow control, temperature, and pressure.

Advantages of RO

Reverse Osmosis is one of the most widely-used water purification techniques used in the pharmaceutical industry. Some of its advantages include the following:

  • Easier to clean and replace parts
  • Requires a relatively simple setup
  • Less expensive

Disadvantages of RO

Even though RO is a popular method when it comes to purified water in pharma, it has some limitations as well. Some of the limitations of the process are:

  • Heavily dependent on the quality of feed water
  • Not effective in getting rid of the dissolved gases in the water
  • Needs pre-treatment 
  • Clogging of the membranes is extremely common and can result in significant downtime

Electro-De-Ionization

Electro De-Ionization, or EDI, is another popular water purification technique that is widely used to purify water for pharmaceutical operations. EDI uses the principle of ionization and electrolysis to eliminate specific ions in the water and replace them with more desirable ones. 

How Does EDI Help?

The process of EDI works extremely well to get rid of ammonia, boron, silica, residual salts, carbon dioxide, and organic contaminants from the water.

Equipment Needed

A relatively simpler method, EDI does not need elaborate paraphernalia. Some of the equipment needed in EDI are:

  • Cell pairs which act as anode and cathodes
  • Power source
  • Resin beds
  • Collection, storage & distribution mechanism

The Process

The EDI module is set up using ion-exchange resin beds and separated by ion- exchanging membranes which are basically high-surface electrodes with positive and negative charges. Then an electric current is passed through the water at right angles, which causes the positively charged cation moves toward the negatively charged anode and the negatively charged anions to move toward the positively charged cathode. As a result of this ion exchange, water is rendered water de-ionized. 

Advantages of EDI

The process of EDI offers some significant benefits for the ease of water purification in pharmaceuticals. Some of its common advantages are:

  • A single EDI unit can be used repeatedly for years without any need for replacement as the process gets rid of the impurities from the system, causing zero build-ups in resins or membranes.
  • It is a green method as it is more sustainable and leads to less wastage
  • Requires no chemical
  • Lower energy consumption
  • No heating required
  • Relatively economical to set up and operate

Disadvantages of EDI

While many advantages offered by EDI have contributed to its popularity in pharmaceutical operations for the generation of purified water, it has its own set of drawbacks as well. Some of the disadvantages of the EDI process are:

It can only remove a limited number of specifically charged organic impurities

It is highly reliant on the quality of the feed water and may require additional pre-treatment procedures depending on the same.

Whether it is RO or EDI, water systems used in the pharmaceutical industry all have their own share of perks and limitations. RO and EDI water systems both have their specific use case, and one cannot replace or substitute another. Current and ongoing technological advancements only promise to make the processes even more efficient to ensure a better quality of pharmaceutical products. 

In order to keep this progress going, it is important to choose the right water treatment company, as it is imperative to any industry, especially pharmaceutical processes. To do this, you need to know your requirements. TSA Water Systems designs water systems for optimal purity and helps you achieve maximum operational efficiency. We strive so that your water purification systems achieve the lowest cost per liter.

Share this post:

For 20 years, we’ve been the go-to problem-solvers for high-purity and injectable process applications in the pharma and biopharma industry. We are relentless about continuous process improvement and upskilling, elevating ourselves and our technology so you can get the job done more efficiently with cost optimisations. Use the form below to schedule a call back from our team.

Name(Required)
This field is for validation purposes and should be left unchanged.

Hetal Panchal is the Vice President in Operations department of TSA Process Equipments (A Thermax Group Company) since 1 s t October 2012.

Holding a qualification in Production Engineering and 28 years of industry experience, he specializes in designing advanced equipment for the pharmaceutical sector. His expertise lies in optimizing production lines, improving efficiency, and ensuring compliance with regulatory standards.
Focused on innovation, he has developed systems that enhances productivity, minimizes downtime, and maintains product quality. Staying current with technological trends, they contribute to ongoing improvements in the industry.
His extensive experience has helped identify opportunities for innovation, streamlining operations and reducing costs. Through his specialized knowledge, more efficient manufacturing processes and higher-quality outputs in pharmaceutical production are delivered.

B.C. Mahesh is the Chairperson of TSA Process Equipment Pvt. Ltd. since Feb 2024.

B.C. Mahesh became a member of the Executive Council in August 2013. He is responsible for the Industrial Product Business (IPB), which consists of Process Heating, Absorption Cooling & Heating Solutions, Water and Waste Solutions, Air Pollution Control, Steam Engineering, Channel Business Group, International Business Group, and Enterprise Sales businesses.
As part of IPB, he also oversees the following wholly-owned subsidiaries
of Thermax – Danstoker, PT Thermax International Indonesia and Rifox.Mahesh joined Thermax as a graduate trainee in 1988 and handled the Materials function for various businesses, including global sourcing, till 1996.
He moved to the Power division(P&ES) and grew to the position of Sales Head and subsequently Head of Projects. He took over as the Head of the SBU for Medium Power Plants in 2009 and finally as Head of Power business in 2012.
Mahesh has worked with Thermax for over 30 years in many functions such as manufacturing, supply chain, sales and marketing, and project management, and has played a significant role in the strategy, expansion and diversification of the Power business.Mahesh completed his Mechanical Engineering from the Visvesvaraya Regional College of Engineering, Nagpur in 1988.

Vishal Mehra is the Director of TSA Process Equipment Pvt. Ltd. since Feb 2024.

Mr. Vishal Mehra is currently serving as the Strategic Business Unit Head for Water & Waste Solutions (WWS) at Thermax Limited. Additionally, he holds a directorial position at TSA Process Equipment, which is known for its expertise in ultra-pure and high-purity water technologies and was recently acquired by Thermax.With over 22 years of experience in the industry, Mr. Mehra’s professional focus includes water management solutions, advanced technology development, and business strategy.
His areas of interest encompass cutting-edge technology, growth strategies, organizational effectiveness, and development.
Mr. Mehra is well qualified in business management and strategy transformation, having completed the Senior Executive Program in Business Management and Strategy Transformation from London Business School. This advanced education supports his extensive experience and expertise in the field.

Sandeep Deshpande has been the Director of TSA Process Equipments Pvt. Ltd. since February 2024.

Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Sandeep is a qualified Cost Accountant Company Secretary, and holds a diploma in IFRS and an advanced diploma in financial management from XLRI. He has extensive experience in financial operations, including financial planning, MIS, budgeting, controlling, audits, and cash flow management. His expertise also spans financial reporting, consolidation, mergers and acquisitions, due diligence, business restructuring, and implementing Internal Financial Control (IFC) and Enterprise Risk Management (ERM). Additionally, Sandeep has hands-on experience with Oracle systems, automation, digitization, and business analytics. He is passionate about driving good governance, improving financial reporting, and leveraging automation and digitization to enhance business analytics.

Rajiv Parikh is the COO of TSA Process Equipments (A Thermax Group Company) since April 2024.

Rajiv is a highly accomplished professional with extensive experience in the pharmaceutical and FMCG sectors, specializing in high-purity and process vessels. He played a key role in establishing TSA Process Equipments Pvt. Ltd., driving its growth and success. His deep technical expertise, combined with a strong understanding of client needs, has enabled him to deliver innovative solutions to complex industry challenges.

Throughout his career, Rajiv has excelled in leadership and sales, consistently launching cutting-edge products that have positively impacted the market. His ability to build lasting client relationships and offer tailored solutions has earned him a reputation as a trusted industry leader.

With a background in Mechanical Engineering, Rajiv blends technical proficiency with strategic vision. His contributions have shaped industry standards and positioned him as a key influencer in the pharmaceutical and FMCG sectors.

Apurva Shah is the CEO of TSA Process Equipments (A Thermax Group Company) since April 2024.

With a career spanning over 24 years, Apurva is the visionary CEO of TSA Process Equipments, where he has led the company to new heights in the High Purity & process equipment industry. A graduate in Mechanical Engineering from Mumbai University, followed by an MBA in Business Management from NMIMS, He brings a strong technical foundation combined with a sharp strategic mindset.

His expertise lies in formulating and executing strategies that drive growth and operational efficiency. Over the years, he has cultivated a deep understanding of market dynamics, positioning TSA Process Equipments for continued success in a competitive landscape.

Outside of his professional pursuits. He is an avid reader, with a particular interest in fiction novels, which fuel his creativity and broaden his perspective.